Publications by authors named "Casey Dorr"

Claim this Profile
S
Simultaneous Prediction of Area Under the Curves of Mycophenolic Acid and Its Metabolites and Enterohepatic Recirculation in Kidney Transplant Recipients.
Moataz E Mohamed, Abdelrahman Saqr, Guillaume Onyeaghala, Rory P Remmel, Christopher Staley, Casey R Dorr

Ther Drug Monit· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited Sampling Strategies Fail to Accurately Predict Mycophenolic Acid Area Under the Curve in Kidney Transplant Recipients and the Impact of Enterohepatic Recirculation.
Moataz E Mohamed, Abdelrahman Saqr, Mahmoud Al-Kofahi, Guillaume Onyeaghala, Rory P Remmel, Casey R Dorr

Ther Drug Monit· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steroid-tacrolimus drug-drug interaction and the effect of CYP3A genotypes.
Abdelrahman Saqr, Mahmoud Al-Kofahi, Moataz Mohamed, Casey Dorr, Rory P Remmel

Br J Clin Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation.
Moataz E Mohamed, Abdelrahman Saqr, Christopher Staley, Guillaume Onyeaghala, Levi Teigen, Casey R Dorr

Transplantation· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges for immunosuppression in the context of pig-to-human xenotransplantation.
Guillaume Onyeaghala, Casey R Dorr, Ajay K Israni

Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extreme phenotype sampling and next generation sequencing to identify genetic variants associated with tacrolimus in African American kidney transplant recipients.
Moataz E Mohamed, Bin Guo, Baolin Wu, David P Schladt, Amutha Muthusamy, Casey R Dorr

Pharmacogenomics J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic risk score for acute rejection based on donor-recipient non-HLA genotype mismatch.
Rui Cao, David P Schladt, Casey Dorr, Arthur J Matas, William S Oetting

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extreme Phenotype Sampling and Next Generation Sequencing to Identify Genetic Variants Associated with Tacrolimus in African American Kidney Transplant Recipients.
Moataz Mohamed, Bin Guo, Baolin Wu, David Schladt, Amutha Muthusamy, Casey Dorr

Res Sq· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Indian Perspectives on Culturally Aligning a Digital Smoking Cessation Resource.
Chelsea Cooley, Wyatt Pickner, Rachel Widome, Dylan Jennings, Antony Stately, Casey Dorr

Nicotine Tob Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing community-engaged pharmacogenomics in Indigenous communities.
Katrina G Claw, Casey R Dorr, Erica L Woodahl

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers.
Kevin A Reininger, Guillaume Onyeaghala, Teresa Anderson-Haag, David S Schladt, Baolin Wu, Casey R Dorr

Clin Transplant· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Potential for a Personalized Medicine Approach to Smoking Cessation With an American Indian Tribe.
Dana Mowls Carroll, Sharon Murphy, Ellen Meier, Kristine Rhodes, Casey Dorr

Nicotine Tob Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry.
Mahmoud Al-Kofahi, William S Oetting, David P Schladt, Rory P Remmel, Weihua Guan, Casey R Dorr

J Clin Pharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
Tam T Nguyen, Rachael A Pearson, Moataz E Mohamed, David P Schladt, Danielle Berglund, Casey Dorr

J Clin Pharm Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups.
Moataz E Mohamed, David P Schladt, Weihua Guan, Baolin Wu, Jessica van Setten, Casey R Dorr

Am J Transplant· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing.
Casey R Dorr, Baolin Wu, Rory P Remmel, Amutha Muthusamy, David P Schladt

Pharmacogenomics J· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A.
William S Oetting, David P Schladt, Casey R Dorr, Baolin Wu, Weihua Guan

Transplantation· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies.
William S Oetting, Baolin Wu, David P Schladt, Weihua Guan, Jessica van Setten, Casey R Dorr

Transplantation· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients.
Stephan R Seibert, David P Schladt, Baolin Wu, Weihua Guan, Casey Dorr

Clin Transplant· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus Elimination in Four Patients With a CYP3A5*3/*3 CYP3A4*22/*22 Genotype Combination.
Aileen Scheibner, Rory Remmel, David Schladt, William S Oetting, Weihua Guan, Casey Dorr

Pharmacotherapy· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics of acute rejection after kidney transplantation.
Casey R Dorr, William S Oetting, Pamala A Jacobson, Ajay K Israni

Transpl Int· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.
William S Oetting, Baolin Wu, David P Schladt, Weihua Guan, Rory P Remmel, Casey Dorr

Pharmacogenomics· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9 Genetic Modification of in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism.
Casey R Dorr, Rory P Remmel, Amutha Muthusamy, James Fisher, Branden S Moriarity

Drug Metab Dispos· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concepts of Genomics in Kidney Transplantation.
William S Oetting, Casey Dorr, Rory P Remmel, Arthur J Matas, Ajay K Israni

Curr Transplant Rep· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.
Casey R Dorr, Barry I Freedman, Pamela J Hicks, W Mark Brown, Gregory B Russell

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis